Ignite Creation Date:
2024-07-17 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466525
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-10
Brief Title:
A Two-Part Single and Multiple Ascending Dose Trial of the Safety Tolerability Pharmacokinetics and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinsons Disease
Sponsor:
Longevity Biotech Australia Pty Ltd subsidiary
Organization:
Longevity Biotech
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-10
First Submit QC Date:
None
Study First Post Date:
2024-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-05
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL